Senior insider sale
EVP and CFO at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$1.38M
3.17K shares
What this filing means
DIER MARDI plans to sell 3.17K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $1.38M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/6/2026ACC: 0001628280-26-015771
Officer· EVP and CFO
Since Mar 2026
3.17K
Shares to sell
$1.38M
Approx. market value
646.00
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Grant
Vesting of Restricted Stock Units
3/5/2026
646.00Total acquired646.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/5/2026 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 646.00 | — |
| Total | 646.00 | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.34K
Market value
$587.0K
3/6/2026
—Completed
Units to sell
1.18K
Market value
$505.4K
3/2/2026
Planned — Approximate Date
Nasdaq Stock MarketPlanned
Units to sell
646.00
Market value
$283.8K
3/6/2026
Total
Units
3.17K
Value
$1.38M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/6/2026 | 1.34K | $587.0K | — | Completed |
3/2/2026 | 1.18K | $505.4K | — | Completed |
| Planned — Approximate Date | ||||
3/6/2026 | 646.00 | $283.8K | Nasdaq Stock Market | Planned |
| Total | 3.17K | $1.38M | ||